PARAMETRIC PORTFOLIO ASSOCIATES LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$3,015,000
-43.7%
77,774
-15.1%
0.00%
-33.3%
Q4 2021$5,359,000
+4.5%
91,593
+5.9%
0.00%0.0%
Q3 2021$5,126,000
-34.9%
86,488
-4.6%
0.00%
-25.0%
Q2 2021$7,871,000
+12.6%
90,687
+7.0%
0.00%0.0%
Q1 2021$6,990,000
-2.4%
84,777
+7.7%
0.00%0.0%
Q4 2020$7,160,000
+192.2%
78,740
+28.5%
0.00%
+100.0%
Q3 2020$2,450,000
+24.6%
61,290
+6.9%
0.00%0.0%
Q2 2020$1,967,000
+45.6%
57,328
-5.7%
0.00%
+100.0%
Q1 2020$1,351,000
+210.6%
60,812
+173.4%
0.00%
Q4 2019$435,000
+39.4%
22,240
+10.6%
0.00%
Q3 2019$312,000
-10.9%
20,110
+16.5%
0.00%
Q2 2019$350,000
+37.3%
17,263
+19.1%
0.00%
Q1 2019$255,000
+33.5%
14,500
-2.6%
0.00%
Q4 2018$191,000
-4.0%
14,886
+22.1%
0.00%
Q3 2018$199,000
+29.2%
12,189
-10.2%
0.00%
Q2 2018$154,000
-83.4%
13,573
-85.7%
0.00%
-100.0%
Q1 2018$929,000
+1155.4%
95,154
+690.7%
0.00%
Q4 2017$74,00012,0340.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders